John A Orwin is of Seagen Inc.. Currently has a direct ownership of 0 shares of SGEN, which is worth approximately $0. The most recent transaction as insider was on Dec 14, 2023, when has been sold 29,003 shares (Common Stock) at a price of $229.0 per share, resulting in proceeds of $6,641,687. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

John A Orwin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 14 2023
SELL
Sale (or disposition) back to the issuer
$6,641,687 $229.0 p/Share
29,003 Reduced 100.0%
0 Common Stock
May 31 2023
BUY
Grant, award, or other acquisition
-
2,044 Added 6.18%
31,047 Common Stock
May 13 2022
BUY
Grant, award, or other acquisition
-
1,503 Added 4.93%
29,003 Common Stock
May 14 2021
BUY
Grant, award, or other acquisition
-
1,402 Added 4.85%
27,500 Common Stock

Also insider at

BCEL
Atreca, Inc. Healthcare
TVTX
Travere Therapeutics, Inc. Healthcare
ANAB
ANAPTYSBIO, INC Healthcare
CRGX
CARGO Therapeutics, Inc.
JAO

John A Orwin

San Carlos, CA

Track Institutional and Insider Activities on SGEN

Follow Seagen Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGEN shares.

Notify only if

Insider Trading

Get notified when an Seagen Inc. insider buys or sells SGEN shares.

Notify only if

News

Receive news related to Seagen Inc.

Track Activities on SGEN